UroGen Pharma Ltd. (URGN) Gross profit 2016–2025
UroGen Pharma Ltd. (URGN) annual gross profit history from SEC filings — each fiscal year as reported.
$97.3MFY2025 · since FY2016: $17.5M → $97.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $97.3M | +19.4% |
| FY2024 | $81.5M | +11.1% |
| FY2023 | $73.4M | +29.4% |
| FY2022 | $56.7M | +32.2% |
| FY2021 | $42.9M | +297.5% |
| FY2020 | $10.8M | +59844.4% |
| FY2019 | $18,000 | +102.7% |
| FY2018 | -$675,000 | -108.9% |
| FY2017 | $7.6M | -56.8% |
| FY2016 | $17.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice